Search Results

Abbott announced late-breaking data for MitraClip™, the leading therapy to treat leaky valves in people with mitral regurgitation, that demonstrate long-term benefits of the device in patients battling heart failure.

Next generation of intuitive control systems for prosthetic upper limbs available now

New data presented and simultaneously published in the Journal of the American College of Cardiology show treatment with MitraClip resulted in significant and sustained long-term quality-of-life improvements compared to medical therapy

The COAPT trial met both the primary safety and efficacy endpoints and all secondary endpoints, including reducing all-cause mortality through two years

TISSIUM, a privately-owned medical technology company developing biomorphic programmable polymers for atraumatic tissue reconstruction, announced today the successful implantations of the first patients with its COAPTIUM Connect Sutureless Nerve Coaptation System as part of its peripheral nerve repair study in Australia.

CoapTech, Inc, a medical device company focused on delivering transformative solutions for minimally-invasive surgery, announced today publication of study results conducted at the University of Maryland Baltimore Washington Medical Center (UM BWMC) comparing percutaneous gastrostomies placed with the PUMA-G System™ to those placed with usual care methods.

CroíValve today announced initiation of its Early Feasibility Study (EFS) for the DUO™ Tricuspid Coaptation Valve System, following FDA IDE and CMS approval.